Concepedia

Thomas A. Mace

TA

Statistics

Publications

50

Citations

3.9K

H-Index

33

Active since

2011

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Emory University

The Ohio State University Wexner Medical Center

Roswell Park Comprehensive Cancer Center

Thomas A. Mace is an author at The Ohio State University specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2011–2024

50

Publications

50

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

Thomas A. Mace, Reena Shakya, Jason R. Pitarresi et al. · Gut · 2016 · 546 citations · Full text

, , +17

Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner

Thomas A. Mace, Zeenath Ameen, Amy Collins et al. · Cancer Research · 2013 · 402 citations · Full text

, , +17

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse et al. · Clinical Cancer Research · 2018 · 236 citations · Full text

, , +17

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Andrew Stiff, Prashant Trikha, Robert Wesolowski et al. · Cancer Research · 2016 · 183 citations · Full text

, , +16

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro

Brooke Benner, Luke Scarberry, Lorena P. Suarez‐Kelly et al. · Journal for ImmunoTherapy of Cancer · 2019 · 182 citations · Full text

, , +16

1–5 of 50